News Medical on MSN10h
RUFY1-RET fusion identified as mechanism of resistance to lorlatinib in lung cancer
A new case report was published in Volume 16 of Oncotarget on February 5, 2025, titled "Acquired RUFY1-RET rearrangement as a mechanism of resistance to lorlatinib in a patient with CD74-ROS1 ...
AI and neural networks can reduce wait times for lesion classification in breast cancer patients
One of the most agonizing experiences a cancer patient suffers is waiting without knowing: waiting for a diagnosis, waiting ...
AI tool converts data into 2D circular images, offering new way to visualize disease
Mayo Clinic researchers have pioneered an artificial intelligence (AI) tool, called OmicsFootPrint, that helps convert vast ...